MedTrace Logo

SHERLOCK 3CG vs. Fluoroscopy in Implantation of PICC-Line

NCT02929368 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2020-03-10

No results posted yet for this study

Summary

Peripherally inserted central catheters, or PICC lines, has now been successfully in use for many years, especially in the chemotherapeutic treatment of oncologic patients or in parenertal nutrition. The implantation of PICC lines is mostly performed under x-ray (fluoroscopy). The aim of the clinical study is to assess the safety and the efficacy of the SHERLOCK-Systems eliminating the confirmatory chest x-ray exposure. Additionally, the SHERLOCK-System immediately confirms the PICC tip position even at the bedside of the patient, thus, saving costs and time.

Conditions

  • Patients With PICC-Line

Interventions

DEVICE

PICC implantation under fluoroscopy

PICC Catheter implantation

DEVICE

PICC Implantation under Sherlock System

PICC Catheter implantation

Sponsors & Collaborators

  • Jena University Hospital

    lead OTHER

Principal Investigators

  • Heike Habrecht, Dr. med. · University Hospital Jena, Germany

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2018-02-28
Completion
2018-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02929368 on ClinicalTrials.gov